首页资讯加强曾患妊娠糖尿病妇女的产后心脏代谢健康：药物和生活方式策略的下一步行

加强曾患妊娠糖尿病妇女的产后心脏代谢健康：药物和生活方式策略的下一步行

来源：泰然健康网时间：2024年12月26日 13:55

加强曾患妊娠糖尿病妇女的产后心脏代谢健康：药物和生活方式策略的下一步行动和未解之谜。

Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

相关文献

二甲双胍通过HDAC6和FoxO3a转录调控肌肉生长抑制素诱导肌肉萎缩

Min Ju Kang, Ji Wook Moon, Jung Ok Lee, Ji Hae Kim, Eun Jeong Jung, Su Jin Kim, Joo Yeon Oh, Sang Woo Wu, Pu Reum Lee, Sun Hwa Park, Hyeon Soo Kim

具有疾病敏感单倍型的非亲属供体脐带血移植后的1型糖尿病

Kensuke Matsumoto, Taisuke Matsuyama, Ritsu Sumiyoshi, Matsuo Takuji, Tadashi Yamamoto, Ryosuke Shirasaki, Haruko Tashiro

来源期刊

Diabetes, Obesity & Metabolism

期刊介绍： Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

期刊最新文献

Diagnostic accuracy of Agile-4 score for liver cirrhosis in patients with metabolic dysfunction-associated steatotic liver disease. A systematic review and meta-analysis of diagnostic test accuracy studies. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial. Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study). Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real-world setting in China. Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases.

加强曾患妊娠糖尿病妇女的产后心脏代谢健康：药物和生活方式策略的下一步行